---
title: "HRTX.US (HRTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HRTX.US/news.md"
symbol: "HRTX.US"
name: "HRTX.US"
parent: "https://longbridge.com/en/quote/HRTX.US.md"
datetime: "2026-05-20T06:46:05.004Z"
locales:
  - [en](https://longbridge.com/en/quote/HRTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HRTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HRTX.US/news.md)
---

# HRTX.US (HRTX.US) — Related News

### [Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility](https://longbridge.com/en/news/286050041.md)
*2026-05-12T06:00:11.000Z*
> Heron Therapeutics Inc (HRTX) faces significant risks due to restrictive covenants in its working capital facility and 2

### [Heron released its outlook for net product sales in 2026, aiming to return to positive adjusted EBITDA](https://longbridge.com/en/news/285986350.md)
*2026-05-11T19:40:32.000Z*
> Heron Therapeutics released its product net sales outlook for 2026, expecting it to be between $173 million and $183 mil

### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/en/news/285977098.md)
*2026-05-11T17:05:55.000Z*
> In Monday's trading session, several health care stocks experienced significant movements. Pomdoctor (POM) surged 185.9%

### [](https://longbridge.com/en/news/285957513.md)
*2026-05-11T12:56:09.000Z*
> Heron Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

### [Heron Therap | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 34.71 M](https://longbridge.com/en/news/285937832.md)
*2026-05-11T12:02:48.000Z*
### [Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 | HRTX Stock News](https://longbridge.com/en/news/284272584.md)
*2026-04-27T13:30:58.000Z*
> Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026 | HRTX Stock News